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Abstract
Gene expression is random owing to the low copy numbers of molecules in a living cell
and the best way to study it is by use of a stochastic method, specifically the chemical
master equation. The method is used here to derive analytically the invariant probability
distributions, and expressions for the moments and noise strength for a simple gene model
without feedback. Sensitivity analysis, emphasizing particularly the dependence of the
probability distributions, the moments, and noise strength is carried out using Metabolic
Control Analysis, which uses control coefficients that measure the response of observables
when parameters change. Bifurcation analysis is also carried out. The results show that the
number of mRNA molecules follows a hypergeometric probability distribution, and that
noise decreases as the number of these molecules increases. Metabolic Control Analysis
was successfully extended to genetic control mechanisms, with the obtained control coef-
ficients satisfying a summation theorem. The system undergoes stochastic bifurcations as
parameters change.
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Preface
I should begin by telling you about the menacing shortcomings in me, when it comes to
Biology. Before joining Professor Roussel’s lab, I had some erratic encounters with Biol-
ogy, but that was long back. If I remember well, the last time I was enrolled in a Biology
class was in high school, and the only word I could remember when I came to Canada was
“photosynthesis”. I am not sure why that word kept lingering in my mind. I think that’s
the truth about life, the word “educated” can remain with us but, as is the case with most
people, most of what we would have learnt never stays with us.
I appreciated Marc’s work when I browsed through his website. Application of Mathe-
matics to a variety of fields, among them Biology and Chemistry. My training previously
centred in Mathematics, Applied Mathematics to be precise. Most Mathematicians would
agree with me that in this field, most of the experts move around with void minds. Defini-
tions and facts are all they need to prove, derive, or extend a theory, support some hypothe-
sis or deduce a solution. The need to recall or memorize is minimal, in contrast to Biology.
Most of the Biology textbooks are a pain to study for people who like proofs, let alone
those who like playing around with figures since, except for the page numbers, they barely
have numbers in them. Be that as it may, the interaction between Mathematics and Biology
is inevitable, and that forced me to compromise and accept ambidexterity, so I studied the
Biology necessary for this work. Apart from that, I am a long way behind.
My apologies to whoever is going to read this piece of work, and in particular, the Biolo-
gists. My Biology background is very shallow, but nonetheless, the biology facts engraved
in this work suffice to set the base for my work. I also boast of a superb supervisory com-
mittee, a meticulously chosen concoction of experts, among them a Biochemist, hence it
was safe to embark on this particular project.
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Chapter 1
Introduction
Cells perform crucial roles in living organisms. Amongst these are decision making, mem-
ory storage and integration of signals. What surprises is that cells manage to execute their
duties in environments characterized by noise. They operate precisely within strict and
safe parameters despite this noise. Noise causes unpredictability of events in cells, which
then respond to changes to maintain order to behavior and development. The strength of the
noise or randomness is termed stochasticity. Perhaps we henceforth need to brace ourselves
for some of the challenging questions inevitable in biology: What is stochasticity? Where
does it originate from? What is the evidence of its existence in biological systems? How
does it affect the modeling of biochemical processes? Most importantly, can we control
stochasticity?
I will attempt to answer the preceding questions one at a time and with reference to a cen-
tral biochemical process, gene expression. Gene expression is not an arbitrary choice; this
work focuses on it for two reasons. Firstly, it would be easier to comprehend stochasticity
by employing some sort of a common case study of it, than just an abstract discussion.
Secondly and most importantly, gene expression forms the basis for the control of many
cellular processes [1].
Therefore, I will try and provide some answers to the above questions with all the attention
concentrated on gene expression. In contrast, my work does not revolve around a particular
gene, but is applicable to a multitude of genes.
1
1.1 Gene Expression
In simple terms, a gene is a piece of the DNA which encodes RNAs for different uses in the
cell, including the manufacture of specific proteins. The DNA stores all the genetic infor-
mation in a cell. The process by which this information is retrieved and converted to “gene
products” is what is termed gene expression. Although genes are randomly expressed, the
expression is triggered. First, signals have to be sent to the gene, then an appropriate re-
sponse is generated due to the regulation of that particular gene. The signals are normally
changes in levels of biomolecules, or changes in conditions in and around the cell. Gene
regulation is carried out by proteins and/or small regulatory RNA’s, e.g the microRNAs,
which act in response to the physiochemical environment. This could be the absence of a
particular biochemical species, changes in temperature, etc. Proteins are synthesized using
instructions carried by messenger RNA (mRNA). The mRNA or messenger ribonucleic
acid is a short, single stranded copy of the DNA which has the same sequence as the cod-
ing strand with the base uracil in place of the base thymine. Thus, information flows from
the gene to the mRNA and eventually to the proteins—the so–called Central Dogma of
Molecular Biology. The flow of information to the mRNA is called transcription, while the
conversion of the mRNA to proteins is called translation.
1.2 Transcription
Information stored by the gene will only be released if the gene has received a signal and
is ready. Some genes are always ready for expression. These normally have the role of
directing a constant and incessant supply of crucial cell commodities, for example, energy.
On the other hand, there are genes that are switched “off” until the need for them to be
switched “on” arises [2–6]. The reader will notice in this work that it is this second type
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of gene that we have put much focus on, although our model also covers a constitutive
gene once the rate at which the gene switches off takes very small values. For these genes,
transitions between the “on” and “off” states are random. This is caused by sudden un-
predictable or random binding/unbinding activities between the gene and the transcription
initiation factors. There are other processes that can activate or inactivate the gene, for
example chromatin formation.
Upstream of the gene is a non–coding piece of the DNA called the promoter. It serves the
purpose of providing sites to which biomolecules bind, amongst them, the Transcription
Factors (TFs) and the RNA polymerase (RNAp) [2, 7, 8]. The former enhance or inhibit
the chances of the latter, the enzyme that catalyzes transcription, to bind to the transcrip-
tion start site. TFs bind to some special regions of the promoter called the operator sites.
There are also other factors that bind to the promoter and block or inhibit transcription,
thus deactivating the gene [1, 6]. It is only after a successful binding of the TFs to the
operator sites that the gene becomes ready to be transcribed. The interesting part about
the binding of the TFs to the operator sites is that it is reversible. The reader will realize
in the following sections that our model puts these reversible binding/unbinding processes
in the forefront of the study, and so do the authors of a number of other studies [2, 8–10].
In [2], the author shows that the TF binding/unbinding mechanism is at the helm of most
of the stochasticity, while [10] defines the origin of the fluctuations in mRNA distributions
as being the transitions in promoter states. The author of [10] takes time to illustrate how
stochastic effects easily spread to other processes, after starting in one process. We have
also emphasized gene activation/deactivation due to the same fact that the randomness em-
anating from these reversible processes is inherited throughout the subsequent processes of
transcription and translation. In gene expression, the gene switches with bias and it is not
surprising at all that at any given time, the gene is more likely to be in one state than in the
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other.
1.3 Translation
After the gene has been transcribed, the product mRNA is later decorded and the informa-
tion it carries is then used to form proteins, through the process of translation. Proteins
are formed by concatenation of amino acids through peptide bonds. A special type of
RNA called transfer RNA (tRNA) is responsible for bringing the residues to the ribosome
which links these residues through condensation reactions. The tRNA is just a short RNA
molecule. It binds to a specific codon (base triplet) on the mRNA, using a complemen-
tary sequence called the anticodon. The mRNA molecules serve as templates from which
proteins are produced (translated) by the ribosome, which monitors the codon–anticodon
base pairings, as well as consolidating the peptide linkages. Although this is an important
process, translation is not covered in this Thesis.
1.4 Stochasticity
Stochasticity is an effect or “force” that has an untimely and random power, which prevents
the exact prediction of the later state of a system based on its previous standing. The
only possible way to try and foretell the evolution of the state of the system affected is by
utilization of probabilities. In fact, a system that evolves stochastically is best monitored
by observing the changes in the probability distributions describing it, as time or conditions
change. This is not easy, hence often some quantitative measures (moments) corresponding
to the distributions, for instance the mean and the variance, are used. In the literature [5], the
word noise has been used. Noise is a measure of the strength of randomness (stochasticity).
Therefore, the “bias” that we acknowledged before in the switching characteristics of the
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gene is a bias of the stochastic process. One cannot tell whether the gene will be active
(“on”) or inactive (“off”) as time evolves, although conditions in a cell may bias the state
toward one or the other outcome.
1.5 Origins of stochasticity in biochemical systems
In a chemical system, reactants are in constant motion (diffusion) and collisions are con-
stantly taking place, some leading to chemical reactions, and others not. Collisions can
also result in changes in kinetic energies of reactants, leading to randomness in individual
reaction events. This is worse if the number of molecules is limited [7–9, 11–13]. As an
example, genes normally appear in at most two copies, whereas the TFs usually occur in
tens in a single cell [14]. It is in such cases that stochasticity becomes dominant, for the
participation of each and every molecule is crucial. Individual reactions change the num-
ber of molecules by small integer amounts. In small populations, the disappearance of a
single reactant molecule represents a large relative change in the population and thus in the
reaction probabilities.
1.6 Evidence of stochasticity in biological systems
Suppose one monitors the number of molecules of a particular gene product. It is true that
with time, the number of the same molecule varies. Similarly, if one observes the distri-
bution of the same type of a gene product in two different cells, one would also observe
a difference in the number of molecules. Genetically identical (clonal) cells may have a
different number of molecules for the same gene product [9, 15]. Stochasticity has been
pointed to as the cause of variability in cells. Stochasticity is significant in signalling path-
ways [16], and is responsible for phenomena such as the synchronization of populations of
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cells [17]. It affects regulation of cells resulting in the observed diversification in pheno-
types [10,18–20]. Fluctuations in the levels of intermediary metabolites caused by stochas-
ticity have been cited as the explanation for the retardation in cell growth and reduction in
metabolic efficiency [18]. The observed loss of synchrony in circadian clocks [21, 22], is
also caused by noise. On the good side of it, noise helps lambda phage in the stochastic
lysis/lysogeny stage switches [24], while E. coli benefits by utilizing it to run and tumble
as a strategy for finding nutrient sources [25]. Yeast cells transition among multiple phe-
notypes, stochastically, which keeps their fitness at an optimum [26]. Regulation of gene
expression is instrumental in some of these processes.
1.7 Stochasticity and the modeling of biological systems
Random events in cells occur by chance, i.e., on the molecular scale, no event is certain
or occurs almost surely. The result is that we can only study the affected systems through
probability distributions. Involvement of stochasticity changes the face of the modeling
strategy entirely. Deterministic approaches become inapplicable, given the small copy
numbers of molecules. Instead, qualitative distinctions in outcomes arise due to randomly
timed events, necessitating the use of stochastic models. The study of these models could
focus on particular aspects, for instance, the qualitative behavioral changes (stochastic bi-
furcations) or the response (sensitivity) in levels of biomolecules of the system as con-
ditions in and around it change. Events are treated as memoryless, that is, they are not
dependent on their previous standing, but only the current state will determine the next
state. They thus belong to a class of Markov processes [31]. In these processes, transitions
from one state to the other are considered, allowing one event (reaction) to occur at a time
and changing the molecule numbers by discrete stoichiometric quantities. The numbers of
molecules are normally used to keep track of the evolution of the system.
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Pertaining to the gene expression process, we consider two different probabilities: the prob-
ability that the system is in a given state at time t, and the transition probability that the
system moves from one state to another in time dt. The system thus has a probability of
exiting a state and reverting back to the state and the difference between these probabil-
ities would give us the rate of change of the probability of being in a certain state. This
probability rate equation is called the Chemical Master Equation (CME) [4, 9, 13, 27–31].
Focusing on the gene and its products, the mRNA and proteins, we can derive an infinite
number of differential equations. These would stand for the two–state phenomenon on the
gene itself and the number of molecules of each product in each state of the gene. The full
set of these joint probability rate equations gives us the CME.
1.8 Controlling stochasticity
The first step in alleviating or utilizing a phenomenon in a system is having some command
over it as it unfolds. Despite the randomness of events inside them, cells function robustly.
How can we explain this robustness? This insight is crucial to understand real organisms.
It also assists in the manufacture of gene networks that are applicable in biotechnology and
therapy.
Now every reaction rate depends on a rate constant whose values can change as conditions
are altered. The key to controlling a reaction rate is therefore knowing the rate constants
with the greatest effect on some particular system output, for example noise. A system
may not change much (insensitivity or robustness) when certain parameters change or may
change significantly (sensitive). Ultimately, controlling a system is all about manipulating
system parameters and assessing its response after some perturbation. The study of the
response of a system as parameters are changed is called sensitivity analysis [32]. We def-
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initely need to know which parameters govern which distribution to carry out sensitivity
analysis, considering that many biochemical processes and hence many parameters are in-
volved.
Biological systems and processes governing them are intricate; the outcome is dependent
on many biochemical processes or reactions. In fact, the control of the production or regu-
lation of metabolites is shared amongst many reactions, with many different rate constants.
This is the biggest challenge in the endeavour to study them. Analytically, one faces the
difficulty of not only many but also long expressions which require the use of advanced
mathematical principles to obtain them. In simulations many trials are required to get rea-
sonable results.
To this end, I have introduced the gist of the problem in everyday language, but the real
analysis will be backed by an exact mathematical framework. I will therefore take some
time and space in this work to introduce the reader to some of the fundamental mathemati-
cal principles at the backbone of this work in sections below.
1.9 Probability
Since we have adopted a probabilistic description of all the events occurring in our system,
it is necessary that we give some background about probability. In this context, it is more
convenient that we refer to some experiment with many likely outcomes or possibilities.
Any attempt of an outcome is called a trial. The outcome of a trial can be any out of a pool
of possible outcomes, or the sample space. This means that its choice is random, hence we
can call the outcome of a trial, X , a random variable. X can come up a number of times in
a random manner. The fraction of times it comes up, or the frequency, should give an idea
of how often to expect it. This is called the probability distribution of X , P(X). Probability
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is bounded, meaning that there is a maximum value for the likelihood of an event, and at
this maximum, the event occurs with certainty or almost surely. There is also a minimum
likelihood, in which case the event should not be expected at all. The values standing for
these likelihoods are 1 and 0 respectively. All the probabilities will be sandwiched between
these values. In mathematical notation, we can write,
0≤ P(X)≤ 1.
The sum of all probabilities for outcomes in a sample space is one, i.e.,
∑
all x
P(X) = 1.
Section 2 of Gillespie’s paper [33], treats the concept of probability so well that it is worth
reading if one wants some more detail. There are two quantities that occur randomly in our
case, the state of the gene, s, and the number of molecules of the gene product, m, both
observed at time t. The state space therefore is the set of all possible pairs, Ω = {s,m},
where s takes the values 0 or 1, corresponding to the “off” and “on” states of the gene,
and m can take any value from 0 to ∞, i.e., m ∈ [0,∞). If X assumes only integer values,
i.e is discrete, the resulting distribution is called a discrete probability distribution. The
state space we have just described is hence a discrete space. Otherwise X would have a
continuous probability distribution. An example of a discrete probability distribution is
the hypergeometric distribution, which defines the number of successes obtained when one
conducts a sequence, n, of draws, without replacement, from a population with a finite
number of elements. The random variable X is itself called the discrete random variable,
and is the function X defined on the probability space (Ω,2Ω,P). X has the purpose of
selecting elements of Ω, which are in the form of ordered pairs (s,m). The set of all
9
subsets of the state space Ω, is given as 2Ω.
1.10 Joint probability distribution
Suppose on the same probability space, (Ω,2Ω,P), we pick two random variables s and m.
A joint probability for these two events can be described as a probability of events including
both quantities s and m.
1.11 Conditional probability
The conditional probability between two events, say s and m, is defined by
P(m|s) = P(m and s)
P(s)
,
where P(m and s) stands for the probability of all the outcomes that include both events.
1.12 Measures of central tendency and variability
One of the crucial roles played by statistical analyses is the characterization of location and
variability of a data set. As time progresses, different numbers of mRNA molecules are
observed owing to stochasticity. A collection of these counts will form data sets, each set
having different measures of central tendency (mean) and dispersion (variance) which
respectively measure the location and variability of the given data set. The shape of a
particular distribution is characterized by the skewness and the kurtosis. The skewness
measures the asymmetry in the distribution of the values of m whereas the kurtosis mea-
sures the peakedness of the data. In statistics, the most convenient way to characterize the
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shape of a distribution is by use of a histogram, a graphical technique that can display both
the skewness and the kurtosis, and the mean and the standard deviation.
1.13 The Chemical Master Equation (CME)
In physics, a master equation is a set of differential equations which describes the evolution
of the probability distribution at a given time as the balance between transitions leading to
each state and transitions removing the system from those states. A central question we
should ask is how does P(s,m) change with time? In other words, how does it evolve?
We begin discussing the CME by acknowledging the work done by Daniel T. Gillespie. The
reader is hereby encouraged to see [33–36] for a detailed coverage of the CME. Mathemat-
ically, we take into account a system with M species, and N reactions occurring indepen-
dently in this system. The system is considered spatially homogeneous, i.e. well-stirred,
and is held at fixed temperature and volume. Let P(x, t) be the probability of being in a
state x at time t, where x ∈ Ω. If we consider a particular reaction Rµ : Ω → Ω, where
µ ∈ {1,2,3, ...,N}, we can define a corresponding propensity function aµ : Ω→ R+ and a
corresponding stoichiometric transition vector νµ, a fixed constant vector. Now the CME
gives the change in the probability of being in a state x ∈ Ω as being a sum of all the
probabilities of coming to x through Rµ in time dt, which is aµ(x− νµ)P(x− νµ, t), less
the sum of all the probabilities of going out of X through Rµ, given by aµ(x)P(x, t). Thus
mathematically, we can write the CME as
∂P(x, t)
∂t
=
N
∑
µ=1
aµ(x−νµ)P(x−νµ, t)−
N
∑
µ=1
aµ(x)P(x, t). (1.1)
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1.14 Metabolic Control Analysis
The word control refers to adjustments made on a system’s output. Verbally, it means the
power or ability to give some direction, to stop or to start something. A distinction should
be made between this word and the word regulation. Regulation refers to the system’s
means or mechanism to preserve variables at some constant levels with time, regardless of
the settings of the external environment. These variables can, for example be temperature,
concentrations, pH, etc. Metabolic control is hence the ability to inflict change(s) to a state
of metabolism when the external environment changes. One can thus measure the change
by utilizing the response by the metabolism to changes in external factors. In a quest to
explain how cells can operate within strict and safe parameters in the presence of noise and
how cells can use noise, for instance to amplify certain responses, it is best to use sensi-
tivity analysis. One form of sensitivity analysis already in use in analysing biochemical
processes is Metabolic Control Analysis (MCA) [37]. It is based on control coefficients
which enable assessment of relative changes in any observable when parameters change.
My work follows a path that has been cleared by a number of researchers [38]. What I only
do in this study is to extend, using already existing tools that were separately developed,
the application of these tools to gene expression. As we will realize in the following sec-
tion, studies have been going on, including research on gene expression itself and MCA,
although not even one of those that I know has taken the route I took–applying MCA to
gene expression.
1.15 Background knowledge
I mentioned before that biochemical systems in which participant molecule numbers are
limited are subject to stochasticity, and that gene expression was no exception. Events in
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these systems occur at random and unpredictably. Maintenance of the behavior of individ-
ual cells, and the system at large, plays a big role in making sure that the system remains
robust to changes within itself and in its environment, as well as even being sensitive to
these changes. So how do cells work normally given the unpredictability of reactions tak-
ing place inside them? Questions such as this have triggered studies in the regulation and
control of biochemical systems [45–49].
Regulation refers to the ability of the system to maintain itself, whereas control involves
external interference with the cellular activities or chemical reactions within the system to
effect changes on the system’s performance. Studies in control theory have been going on
for over 40 years now [50–52]. In 1973 Henrik Kacser and Jim Burns [53] in Edinburgh
proposed theoretical frameworks meant to deal with the regulation of metabolic systems.
A year later, Reinhart Heinrich and Tom Rapoport in Europe embarked on similar stud-
ies [54, 55]. Despite the fact that these studies were independent and named differently,
they both worked on the system’s sensitivity to parameters, applied at steady state. Hein-
rich and Rapoport called their study Biochemical Systems Theory, while Kacser and Burns
decided to name theirs Metabolic Control Analysis (MCA) [54–56].
Traditionally, a rate-limiting step is defined as the slowest step in a pathway. However,
the meaning of “rate-limiting step” should actually be that step in a pathway which pro-
duces the greatest change in the overall flux, once its rate is increased [51]. The main tools
employed by MCA are the control coefficients, which measure quantitatively the response
in observables when parameters change. A greater absolute value for a control coefficient
would then mean greater control [37]. Such quantification enables assessment of the ef-
fectiveness of a particular step, relative to another. Thus, if control coefficients are the
same for several steps, one cannot speak of a single “rate-limiting step”, instead one should
conclude that the control over the overall flux is shared or distributed and existence of a
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“rate-limiting step” becomes some sort of a hypothesis to be verified. It seems there is
some slow reform evolving amongst biologists to a better definition though. For example
a discussion about control coefficients and MCA was presented in a book by David Met-
zler [58].
My work is an application of MCA to the stochastic gene expression process. The simple
stochastic model I use for this purpose, although it is just a caricature which lacks crucial
features exhibited by a real gene expression system, makes the analysis easy. The results,
presented in the form of mathematical expressions as well as their graphical representa-
tions, should form a convenient and reusable toolbox for the analysis of more complex
and more realistic models. Extension of MCA to genetic control mechanisms, and most
importantly, the development of stochastic control coefficients for the moments of the dis-
tributions, is a unique piece of work. The analytical approach has been used before to
study similar models describing the gene expression process [9, 28–30, 63, 68], but these
researches have ended on developing the expressions for the probability distributions and
some of the first four moments. Usually it is only the first two moments that are derived, the
mean and the variance. Paolo Visco and coworkers [4], used a similar analytical approach
to study a DNA–inversion genetic switch model. MCA has been extended to the general
stochastic regime (for e.g. in [59]), where an outline of the development of stochastic con-
trol coefficients for variances and covariances of concentrations and fluxes is given. These
statistics measure the noise or strength of the stochasticity in a system, and are derived from
the moments of the distribution. To date, no one has ever worked on developing stochastic
control coefficients for the moments of the distributions in gene expression. As mentioned
earlier, moments serve to capture the key qualities of a distribution in numerical form.
Knowing how these important quantities respond to changes in parameters allows us to
have a closer look at how the distributions themselves, and the system as a whole, respond
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also. Moreover, the summation theorems governing the control coefficients [37, 60, 61],
enable one to link the behavior of the system variables to the kinetics of the individual en-
zyme catalysed reactions.
However, the use of parametric sensitivity to study the dynamical behavior of systems is
only applicable when small changes in parameters are effected. In principle, the system is
allowed to settle to a steady state before a small disturbance is inflicted to see if it reverts
back to the original steady state. Large perturbations are not covered by MCA, although
research has started which aims to extend the scope of MCA to large parameter changes.
Vassily Hatzimanikatis [64] proposed a nonlinear MCA model which allows determination
of control coefficients as functions of the metabolic parameters and aimed at enabling the
use of MCA in large parameter changes. The work of Small and Kacser [65,66], which con-
siders linear kinetics is another attempt to extend MCA to cover large parameter changes.
We can also study the behavior of a system in response to large changes in its parameters
by using other methods that are not related to MCA, for example, bifurcation analysis. I
use both of these methods, MCA and bifurcation analysis, to study gene expression so as
to give the reader a complete picture of how the system behaves in the cases of both small
and large parameter changes. The outline of my work is as follows.
In Chapter 2, I present a description of the simple gene expression model which I used,
and its analysis. Chapter 3 contains the development of the stochastic control coefficients,
their interpretation and an illustration of the fulfilment of one of the summation theorems.
Bifurcation analysis together with a study of the same model using simulation is done in
Chapter 4. The simulation is done to enable a comparison of my results with other re-
searchers’ work on a similar model. Lastly, in Chapter 5, I discuss my findings, present
some concluding remarks and also give some future direction of this work.
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Chapter 2
The Simple Gene Expression Model
2.1 Determining the distributions of biomolecules
It would be interesting to obtain expressions for the probabilities, in terms of the param-
eters. However, this involves solving the CME, which is an infinite set of differential
equations. Real systems are represented by large and more complex models but it is hard
to analytically solve the resultant CMEs. This is the reason why the model used in this
study is simple, and represents those genes which switch on and off. Larger and more
realistic models are studied through simulations but, unfortunately, one may not obtain ex-
pressions for the probability functions from this method. Analytical methods tend to enable
researchers to focus on the content of a model, as opposed to its implementation through a
simulation.
Thus, we consider and develop analytic solutions to the simple constitutive gene expres-
sion model depicted in a diagram below. Compared to simulation, there are a number of
advantages that we get by using an exact approach. For instance, knowledge about model
parameters, i.e. the biochemical rate constants of the underlying biochemical reactions, is
something quite rare. In analytical methods, expressions for the probability distributions
are obtained in terms of the parameters. Thus, an analytical approach leads to equations
and allows one to be able to select parameters and try them easily and quickly. Unlike
simulations, equations are reusable. Other researchers can use the already available equa-
tions by merely putting in the parameters appropriate to their situation of interest. Also,
it is difficult to get derivatives which are required to obtain control coefficients by using
simulation results.
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Using the analytical approach, we calculate the stationary probability distributions of the
biomolecules (reactions) constituting gene expression. This means that the probability dis-
tributions do not depend on time. Studying the stationary distributions enables us to only
study the changes on these distributions due to changes in parameters, thereby eliminating
the need to consider that these distributions change as time changes. The aim is to un-
derstand the complications of gene expression profoundly but through a simple model. A
simple model provides one with insight into larger and more realistic models. This build-up
process allows assessment of the effects of changing biochemical rates on the distributions
of crucial (basic) biomolecules without having to worry about complications arising as
more biochemical players add in.
elimination
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‘‘off’’ ‘‘on’’
m k
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Figure 2.1: The model diagram
In this diagram, the constants kon, koff, km and kp denote rate constants for gene activa-
tion, gene deactivation, mRNA and protein production respectively, whereas k−m and k−p
respectively indicate rate constants for mRNA and protein elimination by degradation into
constituents, covalent modification or use to form more complex molecules. We begin the
analysis by outlining some assumptions of the model.
17
2.2 Assumptions of the model
1. mRNA is produced only when the gene is active.
2. mRNA production is not regulated, that is there is no feedback. This means that
proteins produced in the translation process will not affect gene expression. Also, all
the rates mentioned above are constant, i.e. they do not depend on any time-varying
or concentration-dependent quantities.
3. The probability of two reactions occurring simultaneously is infinitesimal, a basic
assumption of the master equation modeling [33].
2.3 Objectives of the study
The objectives of this study are:
1. To derive the joint probability distribution for the state of the gene and the number of
mRNA molecules, i.e. P(s,m) and hence the marginal probability distribution
P(m) =
1
∑
s=0
P(s,m).
2. To derive the conditional probability distributions P(m|s).
3. To derive the expressions for the moments for both the marginal and the conditional
probabilities.
4. To derive the expressions for the control coefficients for the moments mentioned
above. We also determine if these coefficients fulfill some summation theorems.
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5. To study the stochastic bifurcations that the system undergoes when parameters are
changed.
6. To study the same model using numerical simulations and compare the results.
2.4 Analysis of the Model
We get two chemical master equations for the evolution of mRNA molecules, depending
on the state of the gene as shown below:
dP(1,m, t)
dt
= konP(0,m, t)− (koff+ km+ k−mm)P(1,m, t)
+k−m(m+1)P(1,m+1, t)+ kmP(1,m−1, t), m≥ 1 (2.1)
and
dP(0,m, t)
dt
= koffP(1,m, t)+ k−m(m+1)P(0,m+1, t)
−(kon+ k−mm)P(0,m, t), m≥ 0. (2.2)
P(1,m, t) and P(0,m, t) are the probability distributions of the mRNA molecules when
the gene is “on” and “off” respectively. Eqs. (2.1) and (2.2) are infinite sets of ordinary
differential equations since m can take any nonnegative value. A special case of Eq. (2.1)
arises when the gene is “on” and there are no mRNA molecules. This is tantamount to
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taking m = 0 in Eq. (2.1), which gives
dP(1,0, t)
dt
= konP(0,0, t)+ k−mP(1,1, t)− (koff+ km)P(1,0, t),
considering the boundary conditions P(s,−1, t) = 0. Assuming stationarity, i.e. probabili-
ties not dependent on time, we obtain
P(0,m) =
1
kon
[(koff+ km+ k−mm)P(1,m)− k−m(m+1)P(1,m+1)− kmP(1,m−1)], (2.3)
from (2.1), where we have dropped the variable t since we aim to obtain the stationary
probability distributions. Similarly we obtain the special case
P(0,0) =
1
kon
[(koff+ km)P(1,0)− k−mP(1,1)]. (2.4)
Eq. (2.3) gives P(0,m), and hence P(0,m+ 1) in terms of P(1, ·), which enables us to
eliminate P(0, ·) from the problem of solving for the stationary states. Substituting our
P(0,m), and P(0,m+1) in Eq. (2.2) gives
[km(kon+ k−m)+ k
−
m(2km+ kon+ koff)m+(k
−
m)
2m2]P(1,m)
−[k−m(kon+ km+ koff+ k−m)+2(k−m)2m](m+1)P(1,m+1)
+(k−m)
2(m+1)(m+2)P(1,m+2)− km(kon+ k−mm)P(1,m−1) = 0, m≥ 1. (2.5)
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Equation (2.5) can be solved for P(1,m) by first defining, respectively for the “on” and
“off” states, the moment generating functions
F(s,z) =
∞
∑
m=0
zmP(s,m), |z| ≤ 1. (2.6)
We then multiply equation Eq. (2.5) throughout by zm and sum over m. The result is the
second-order differential equation
γ(1− z)F ′′(z)+(βz−1)F ′(z)+ηF(z) = 0, (2.7)
where,
γ =
k−m
kon+ koff+ km+ k−m
, β = γα and η =
γα(kon+ k−m)
k−m
, where α =
km
k−m
.
Note that in Eq. (2.7) we have just dropped the first argument of F(1,z) for ease of presen-
tation. It is easy to show that Eq. (2.7), after a change of variables, transforms to Kummer’s
differential equation
uzF ′′(uz)+(ψ−uz)F ′(uz)− εF(uz) = 0, (2.8)
where
uz = α(z−1), ψ = 1+ kon+ koffk−m
and ε = 1+
kon
k−m
.
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2.5 Solutions of Kummer’s differential equation
Eq. (2.8) has the form of Kummer’s differential equation and has two independent solutions
[31], which we denote as 1F1(ε;ψ;uz) and U(ε;ψ;uz) with
1F1(ε;ψ;uz) =
∞
∑
n=0
1
n!
(ε)n
(ψ)n
unz
and
U(ε;ψ;uz) =
pi
sin(piψ)
(
1F1(ε;ψ;uz)
Γ(1+ ε−ψ)Γ(ψ) −u
1−ψ
z
1F1(1+ ε−ψ;2−ψ;uz)
Γ(ε)Γ(2−ψ)
)
.
1F1(ε;ψ;uz) is the confluent hypergeometric function. (ζ)n denotes the Pochhammer sym-
bol or the rising factorial and is given by
(ζ)n = ζ(ζ+1)...(ζ+n−1) = Γ(ζ+n)Γ(ζ) ,(ζ)0 = 1. (2.9)
Therefore, the general solution of Eq. (2.8) is F(uz) = µ 1F1(ε;ψ;uz)+k U(ε;ψ;uz), where
µ and k are constant coefficients. However, U(ε;ψ;α(z−1)) is unbounded near z = 1, yet
F(1,z) should satisfy limz→1 F(1,z) ≤ 1 according to Eq. (2.6). These conditions ensure
that k = 0. Hence we find that
F(1,z) = µ
∞
∑
n=0
1
n!
(ε)n
(ψ)n
unz = µ 1F1(ε;ψ;uz). (2.10)
Using Eqs. (2.3), (2.6) and taking, as noted in [39],
d
dz 1
F1(ε;ψ;uz) = α
ε
ψ 1
F1(ε+1;ψ+1;uz), (2.11)
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we have
F(0,z) =
µ α
ε−1
[(
ψ− ε
α
+(1− z)
)
1F1(ε;ψ;uz)− εψ(1− z) 1F1(ε+1;ψ+1;uz)
]
=
α
ψ−1
[(
ψ− ε
α
+1− z
)
1F1(ε;ψ;uz)− εψ(1− z) 1F1(ε+1;ψ+1;uz)
]
, (2.12)
after substituting the value of µ calculated below. The constant µ can easily be obtained
from the normalization condition, F(1,1)+F(0,1) = 1. Following our steps, we conclude
from Eqs. (2.10), (2.12) and the normalization condition that
µ =
kon
kon+ koff
=
ε−1
ψ−1 .
Considering the state S(t) of the promoter, the master equation involving the probability
rate for the evolution of the “on” state, dP(1, t)dt , can be written as
dP(1, t)
dt
+(kon+ koff)P(1, t) = kon,
which, when solved, gives
P(1, t) =
ε−1
ψ−1 [1− exp(−(kon+ koff)t)].
Hence, we observe that
ε−1
ψ−1 = limt→∞ P(1, t). (2.13)
23
2.6 Expressions for the probability distributions
One can obtain the probabilities as stated in [29], since from Eq. (2.6) one obtains that
P(1,1) =
d
dz
F(1,z)
∣∣∣∣
z=0
,
P(1,2) =
1
2!
d2
dz2
F(1,z)
∣∣∣∣
z=0
,
P(1,3) =
1
3!
d3
dz3
F(1,z)
∣∣∣∣
z=0
.
One can therefore easily show by induction that
P(1,m) =
1
m!
dm
dzm
F(1,z)
∣∣∣∣
z=0
.
Therefore,
P(1,0) =
1
0!
F(1,z)
∣∣∣∣
z=0
=
ε−1
ψ−1 1F1(ε;ψ;u0),
P(1,1) =
1
1!
d
dz
F(1,z)
∣∣∣∣
z=0
= α
ε
ψ
ε−1
ψ−1 1F1(ε+1;ψ+1;α(z−1))
∣∣∣∣
z=0
= α
ε
ψ
ε−1
ψ−1 1F1(ε+1;ψ+1;u0),
while,
P(1,2) =
1
2!
d2
dz2
F(1,z)
∣∣∣∣
z=0
=
1
2!
α2
ε
ψ
ε−1
ψ−1
ε+1
ψ+1 1
F1(ε+2;ψ+2;u0).
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As seen below, we can prove by induction that
P(1,m) =
αm
m!
ε−1
ψ−1
(ε)m
(ψ)m
1F1(ε+m;ψ+m;u0). (2.14)
Theorem 1 The stationary probability distribution for the number of mRNA molecules
transcribed from an active unregulated gene follows a confluent hypergeometric proba-
bility distribution. Specifically, the distribution is of the form presented in Eq. (2.14).
Proof:
We have shown above that Eq. (2.14) is true for the probabilities of having 1 or 2 mRNA
molecules. Suppose it is true up to some particular value m. We want to prove that
P(1,m+1) =
αm+1
(m+1)!
(ε)m
(ψ)m
ε−1
ψ−1
(ε+m)
(ψ+m) 1
F1(ε+m+1;ψ+m+1;u0).
Now, from Eq. (2.14).
P(1,m+1) =
1
(m+1)!
dm+1
dzm+1
F(1,z)
∣∣∣∣
z=0
=
1
(m+1)!
d
dz
[
dm
dzm
F(1,z)
]∣∣∣∣
z=0
=
1
(m+1)!
d
dz
[
αm
ε−1
ψ−1
(ε)m
(ψ)m
1F1(ε+m;ψ+m;α(z−1))
]∣∣∣∣
z=0
=
αm+1
(m+1)!
(ε)m
(ψ)m
ε−1
ψ−1
(ε+m)
(ψ+m) 1
F1(ε+m+1;ψ+m+1;u0).
To derive an expression for P(0,m), we first replace m by m+1 and m−1 in the expression
for P(1,m) to obtain, respectively
P(1,m+1) =
αm+1
(m+1)!
ε−1
ψ−1
(ε)m+1
(ψ)m+1
1F1(ε+m+1;ψ+m+1;u0), (2.15)
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P(1,m−1) = α
m−1
(m−1)!
ε−1
ψ−1
(ε)m−1
(ψ)m−1
1F1(ε+m−1;ψ+m−1;u0), (2.16)
and then substitute these in Eq. (2.3). Using the definition of the rising factorial given
above, it follows that (ε)m+1 = ε(ε+1)...(ε+m) = (ε)m(ε+m), and similarly, one should
easily deduce that (ε)m+n = (ε)m(ε+m)n. We therefore make the following simplifications.
(ε)m+1
(ψ)m+1
=
(ε)m
(ψ)m
(ε+m)
(ψ+m)
,
while
(ε)m−1
(ψ)m−1
=
(ε)m
(ψ)m
(ψ+m−1)
(ε+m−1) .
Substituting these in Eq. (2.3), we deduce the expression for P(0,m) as
P(0,m) =
αm
(ψ−1)m!
(ε)m
(ψ)m
[
(α+ψ+m− ε) 1F1(ε+m;ψ+m;u0)
−α ε+m
ψ+m 1
F1(ε+m+1;ψ+m+1;u0)
−mψ+m−1
ε+m−1 1F1(ε+m−1;ψ+m−1;u0)
]
. (2.17)
The marginal probability distribution function can easily be recovered by summing the joint
probabilities over all possible values of m. This assists in cases where the same copy of a
particular gene occurs in separate cells. Even if the probability that this particular gene is
active may be known, it may not be clear in which cells this gene is active. It would be
interesting to be able to predict the distribution of the number of mRNA molecules at any
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time that can be transcribed from this gene, i.e. the probability P(m) of having m mRNA
molecules irrespective of the state of the gene. The marginal distribution of m is
P(m) =
1
∑
s=0
P(s,m) = P(0,m)+P(1,m).
The above expressions for P(0,m) and P(1,m) can be described as the probabilities of
being in a state s and obtaining m molecules. In other words, they are simply the joint
probability distributions. Mathematically, they are best interpreted as intersections of two
sets of probabilities, P(s)∩ P(m). Dividing these joint probability distributions by the
probability that the promoter is in a state s leaves one with the conditional probabilities.
We derive and present these in the following section.
2.7 Conditional probabilities
As described above, the joint probability, P(1,m) =P(1)∩P(m), is an intersection between
the probability that the gene is active and the probability of obtaining m mRNA molecules.
Generally, the conditional probability P(m|s), which is the probability of having a certain
number m of molecules of mRNA given that the gene is in a state s, is found by using the
relationship
P(m|s) = P(m)∩P(s)
P(s)
=
P(s,m)
P(s)
.
Using the above relationship, we find the following expressions for the conditional proba-
bilities P(m|1) and P(m|0),
P(m|1) = P(1,m)
µ
=
αm
m!
(ε)m
(ψ)m
1F1(ε+m;ψ+m;u0) (2.18)
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and
P(m|0) = P(0,m)
1−µ =
αm
(ψ− ε)m!
(ε)m
(ψ)m
[
(α+ψ+m− ε) 1F1(ε+m;ψ+m;u0)
−α ε+m
ψ+m 1
F1(ε+m+1;ψ+m+1;u0)
−mψ+m−1
ε+m−1 1F1(ε+m−1;ψ+m−1;u0)
]
. (2.19)
The probabilities relating to the state of the promoter are P(1) = µ = ε−1ψ−1 and P(0) =
1−µ= ψ−εψ−1 . We will derive the marginal probability distributions in a section below. In the
meantime, we take a look at the moments related to the conditional probability distributions
we have just obtained.
2.8 Moments of the distribution
In a stochastic environment like the one which we are analysing, the number of molecules
continuously fluctuates. Instead of focusing on the instantaneous number of molecules, one
should speak of average numbers and deviations from these averages. These are expressed
as functions of the model parameters and are expected to change as these parameters are
changed. One can therefore make inferences about the effect of a change of any parameter
appearing in these expressions. The key qualities of a distribution are captured in numerical
form by measures known as moments. Presented below are some derivations of the expres-
sions for the most important moments, the first (or mean) and the second (van Kampen,
1992). Our aim is to derive the moments for the marginal distributions, a task we cannot
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do directly without traversing through two other kinds of moments, the factorial and condi-
tional moments. The following two sections contain detailed derivations of these two sets
of moments.
2.9 Factorial moments
A factorial moment is the expectation value of the rising factorial defined in Eq. (2.9).
It is found by differentiating the moment generating functions in Eqs. (2.10), (2.12), and
evaluating the results at z = 1. The first and second derivatives give the first and second
factorial moments respectively. The ordinary moments of the distributions can be recovered
from the factorial moments. We first define Es as a partial expectation value, given by
Es( f (m)) =
∞
∑
m=0
f (m)P(s,m).
Next, we ascertain that if νs,i is the ith factorial moment when the gene is in a state s, then
νs,i := Es
[
m!
(m− i)!
]
=
(
diF(s,z)
dzi
)∣∣∣∣
z=1
. (2.20)
This can be proved easily, since mathematically
Es
[
m!
(m− i)!
]
= Es[m(m−1)...(m− i+1)]
=
∞
∑
m=0
[m(m−1)...(m− i+1)]P(s,m) =
∞
∑
m=0
[m(m−1)...(m− i+1)]P(s,m)zm−i
∣∣∣∣
z=1
=
∞
∑
m=0
P(s,m)
di
dzi
zm
∣∣∣∣
z=1
=
di
dzi
[ ∞
∑
m=0
zmP(s,m)
]∣∣∣∣
z=1
=
diF(s,z)
dzi
∣∣∣∣
z=1
.
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The probabilities in Eqs. (2.6) converge absolutely to zero since the moment generating
functions converge, which allows us to commute the summation and differential operators
in the above steps. In fact, from Eqs. (2.10), (2.12), we have
∀z1,z2 ∈ {z : |z| ≤ 1},z1 6= z2 ⇒ F(s,z1) 6= F(s,z2).
Thus F(s,z) is one-to-one. However, it is possible that P(s,m1) = P(s,m2) when m1 6= m2,
where m1,m2 ∈ [0,∞) meaning that for some parameters, P(s,m) vs m has a maximum.
Since
|F(s,z)|=
∞
∑
m=0
|zmP(s,m)|=
∞
∑
m=0
|zm||P(s,m)| ≤
∞
∑
m=0
|P(s,m)|,
and ∑∞m=0 P(s,m) ≤ 1, then ∑∞m=0 P(s,m) is absolutely convergent. Using our moment
generating functions in Eqs. (2.10), (2.12), the first two factorial moments can be derived
as
νs,1 =
dF(s,z)
dz
∣∣∣∣
z=1
=
[ ∞
∑
m=0
mzm−1P(s,m)
]∣∣∣∣
z=1
=
∞
∑
m=0
mP(s,m).
d2F(s,z)
dz2
∣∣∣∣
z=1
=
[ ∞
∑
m=0
m(m−1)zm−2P(s,m)
]∣∣∣∣
z=1
=
∞
∑
m=0
m(m−1)P(s,m) =
∞
∑
m=0
m2P(s,m)−
∞
∑
m=0
mP(s,m)
= Es(m2)−Es(m) = Es(m2)−νs,1,
⇒ νs,2 = d
2F(s,z)
dz2
∣∣∣∣
z=1
= Es(m2)−Es(m).
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Therefore, the second moment in a state s is the sum of the first and second factorial mo-
ments in that state, i.e.
Es(m2) = νs,2+νs,1 =
d2F(s,z)
dz2
∣∣∣∣
z=1
+νs,1. (2.21)
From Eq. (2.11)
diF(1,z)
dzi
= αi
ε−1
ψ−1
(ε)i
(ψ)i
1F1(ε+ i;ψ+ i;uz),
such that
ν1,i =
[
αi
ε−1
ψ−1
(ε)i
(ψ)i
1F1(ε+ i;ψ+ i;uz)
]∣∣∣∣
z=1
= αi
ε−1
ψ−1
(ε)i
(ψ)i
.
If we consider, for instance i = 1 and i = 2, then we get
E1(m) = α
ε−1
ψ−1
ε
ψ
, (2.22)
and
ν1,2 = α
ε+1
ψ+1
E1(m). (2.23)
In a similar fashion, we derive the first and second factorial moments, for the “off” state.
Differentiating once the expression for F(0,z) presented in Eq. (2.12) above, followed by
the substitution z = 1, we find the first “off” state (factorial) moment to be
E0(m) =
α
ψ
ε−1
ψ−1(ψ− ε), (2.24)
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while the related second factorial moment is found as
ν0,2 =
αε
ψ+1
E0(m). (2.25)
2.10 The conditional moments
The partial moments that we derived above are useful in giving us the conditional moments.
These will assist in capturing the qualities of the statistics of a distribution, given a certain
state of the gene. We can thus define, quantitatively, the mean, the variance and the level of
stochasticity, given that the gene is in a particular state. The moments already derived above
represent an intersection of the set of values of a given statistic and the state of the gene.
To obtain the conditional moments, we divide each moment by the respective probability
of the state of the gene. In this respect, we take 〈m j〉s as the jth conditional moment when
the gene is in a state s, such that
〈m j〉s =
∞
∑
m=0
m jP(m|s) =
∞
∑
m=0
m j
P(s,m)
P(s)
=
1
P(s)
∞
∑
m=0
m jP(s,m) =
Es(m j)
P(s)
. (2.26)
For instance, we find that the first conditional moment given that the gene is active would
be found as
〈m1〉1 =
∞
∑
m=0
mP(m|1) =
∞
∑
m=0
m
P(1,m)
P(1)
=
ψ−1
ε−1
∞
∑
m=0
mP(1,m), (2.27)
that is,
〈m1〉1 = E1(m
1)
P(1)
=
α ε−1ψ−1
ε
ψ
ε−1
ψ−1
= α
ε
ψ
. (2.28)
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Using Eq. (2.26), we get that
〈m2〉1 = 1µE1(m
2) =
1
µ
[ν1,2+E1(m)],
simplifying to
[
α
ε+1
ψ+1
+1
]
E1(m)
µ
=
[
α
ε+1
ψ+1
+1
]
〈m1〉1. (2.29)
When the gene is inactive, we find that
〈m1〉0 = αψ(ε−1), (2.30)
while
〈m2〉0 =
[
αε
ψ+1
+1
]
〈m1〉0. (2.31)
2.11 Marginal probabilities and their moments
The marginal distribution described in section 2.6 above is given by
P(m) = P(0,m)+P(1,m) =
αm
(ψ−1)m!
(ε)m
(ψ)m
[
(α+ψ+m−1) 1F1(ε+m;ψ+m;u0)
−α ε+m
ψ+m 1
F1(ε+m+1;ψ+m+1;u0)
−mψ+m−1
ε+m−1 1F1(ε+m−1;ψ+m−1;u0)
]
. (2.32)
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Suppose 〈m j〉 represents the jth moment for the marginal distribution, where j ∈ [0,∞),
then
〈m j〉=
∞
∑
m=0
m j[P(0,m)+P(1,m)] = E0(m j)+E1(m j). (2.33)
The case j = 0 simply gives ∑∞m=0[P(0,m)+P(1,m)] = 1, the normalization condition for
the joint distribution. For j = 1 and j = 2, we find that
〈m〉 = E0(m)+E1(m),
〈m2〉 = E0(m2)+E1(m2) = ν0,2+ν1,2+E0(m)+E1(m),
giving us
〈m〉 = α ε−1
ψ−1 (2.34)
〈m2〉 =
(
1+
αε
ψ
)
〈m〉. (2.35)
The first moment signifies the mean, 〈m〉, or the average number of mRNA molecules.
Using the two moments above, we can deduce an expression for the variance, σ2, which
measures the spread of the numbers of the mRNA molecules, m, from their mean. We find
that,
σ2 = 〈m2〉−〈m〉2 =
[
αε
ψ
+1−〈m〉
]
〈m〉. (2.36)
Using the variance, we can get a second useful statistic, the standard deviation, by simply
computing its square root. The standard deviation tells us how much each of the observed
number of mRNA molecules, on the average, varies from the mean, 〈m〉. A larger value for
the standard deviation implies greater variability around the mean. Since a mean allows an
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entire distribution of the numbers of mRNA molecules to be characterized by an individual
score, its reliability diminishes as the standard deviation becomes larger.
Considering the dynamics on the promoter and the mRNA dynamics we can define pa-
rameters α, Keq and ε. The first parameter is a ratio of rate constants for mRNA synthe-
sis/degradation and is hence related to mRNA dynamics. Keq is an equilibrium constant
for the state of the promoter and is thus a ratio of the rate constants for gene activa-
tion/deactivation. The third parameter, ε, links the time scales of these two subsystems,
i.e. α = km
k−m
,ε = 1+ kon
k−m
and Keq = konkoff . Now, in terms of these parameters, the standard
deviation can be expressed as
σ =
√
αKeq[Keq(ε(2+Keq)+α−1)+ ε−1]
(1+Keq)2(ε(1+Keq)−1) , (2.37)
and we find that as Keq → ∞, σ→
√
α. Thus as Keq becomes large, the standard deviation
is only affected by the mRNA dynamics. In Fig. 2.2 below we plot the standard deviation,
σ, for the marginal probability distribution, against one of the parameters, Keq. This figure
shows that variability increases as the parameter Keq increases. Increasing the parameter
Keq is similar to keeping the gene more into the active state and hence more molecules are
produced and the variability thus increases. The observable however reaches a maximum
value of 2.59 as the parameter Keq → ∞, and is zero when Keq is zero. A similar behavior
was observed for the relationship between the observables σ0,σ1,〈m〉, 〈m1〉0, 〈m1〉1 and
the parameter Keq.
35
Figure 2.2: Behavior of the standard deviation for the marginal distribution, σ, as Keq is
varied, with α = 6.7 and ε = 3 (as in [40]).
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2.12 Noise and its measures
One way to study genetic control mechanisms is by analysing expressions that relate to the
strength of the noise. Mathematically, the strength of the noise is measured by using the
coefficient of variation, CV, which is defined as the ratio of the standard deviation to the
mean of the distribution [42]. It is dimensionless and serves the purpose of revealing the
magnitude of the ratio of a typical fluctuation to the mean. The mean itself is accompa-
nied by some disadvantages which make it unsuitable for use in the interpretation of data
when sampling. For example, it is affected by extreme values in a data set, the larger the
values sitting at the end points of the set, the larger the mean of the whole data set. When
we say the standard deviation helps in telling us about the variability, it does not really
mean we can depend on it. More so, a lower standard deviation does not necessarily mean
less variable data. As an example, we can assume that we have two data sets, one with a
mean value of 60 and standard deviation 10, and a second one with 0.10 and 0.40 for the
mean and standard deviation respectively. Thus we could say the first data set has a greater
variability as compared to the second set based on the standard deviations. However, upon
computing the CV, we find that these two data sets have CVs of values 0.17 and 4 respec-
tively, which contradicts our initial conclusion in favor of a new one, that there is greater
variability in the second data set. The CV measures variability relative to the mean and is
hence preferable for many purposes.
TF binding/unbinding is one source of noise which should not be neglected in all models
designed to model mRNA and protein distributions [28]. Investigating the behaviour of the
CV as Keq changes assists us in corroborating this fact. Our results reveal a decaying plot
of the CV against Keq (Fig. 2.3). Noise is high in all the parameter (kon and koff) regimes
favouring small values of Keq. Thus the efficiency of the binding of transcription factors to
enable transcription plays a significant role in determining the magnitude of the fluctuations
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originating from the activation and deactivation of the gene. As a rule of thumb, noise, η,
is inversely proportional to the square root of the number of molecules, η ∝ 1√m [63, 69].
Increasing Keq is tantamount to keeping the gene in the active state more often than it is kept
inactive. This would ensure an increase in the number of mRNA molecules, thereby less-
ening the noise levels. The reverse is also true. Figure 2.3 illustrates that, unless the gene
is assumed to be active always [68], as can be the case with other genes, for instance the
so-called housekeeping genes, binding and unbinding of transcriptional factors on operator
sites should not be ignored as a major source of intrinsic noise. Noise is inherent in stochas-
tic systems and it would not be accurate to consider fluctuations only at the transcriptional
and translational levels as important in models. Gene activation and deactivation processes
are never equiprobable, stochasticity causes bias towards one of these processes more than
to the other, at any time. The effect of such bias is observed in the uneven distribution or
bursts of the gene products, e.g mRNA, with time [40, 68].
Using our analytic expressions for the mean and the standard deviation above, Eqs. 2.34
and 2.38, we find that noise is inversely proportional to the parameter α. Moreover, as
Keq → ∞,CV→ 1√α .
Fig. 2.3 shows that the CV reduces to a minimum, found to be 0.082, as Keq →∞, implying
that the strength of the noise pegs at a constant low level as the number of molecules keeps
increasing. The noise strength correspondingly increases as Keq decreases.
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Figure 2.3: A plot of the coefficient of variation against the equilibrium constant, Keq, while
α = 150, ε = 72000 (as in [30]).
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2.13 The skewness and the kurtosis
We considered the number of mRNA molecules, m, as a random variable with mean 〈m〉
and variance σ2 calculated above. Two more important moments for the marginal distri-
bution of m can still be calculated. These are the third and fourth moments, called the
skewness and the kurtosis respectively.
The skewness measures the asymmetry in the distribution of the values of m. We can easily
get a picture of whether the distribution has a longer tail or a shorter tail, to the left or to
the right of the mean value by observing the sign and magnitude of the third moment. A
positive value indicates a longer tail to the right, in contrast to a negative skewness, marked
by a longer tail to the left.
The excess kurtosis measures the peakedness of the data compared to the normal distribu-
tion, which has an excess kurtosis of zero. A distribution with a negative excess kurtosis is
described as platykurtic, and the opposite is described as leptokurtic. A platykurtic distri-
bution has a broad, slowly decaying maximum. When the kurtosis is greater than zero or
positive, the curve is strongly peaked and we find a large area squashed into a small range
of the distribution. We have to be aware that although two distributions may have the same
variance and approximately the same value for the skewness, they may differ markedly
when it comes to the kurtosis.
Mathematically, the two are standardized third and fourth central moments, where the rth
standardized central moment is given by
E
[(
m−〈m〉
σ
)r]
. (2.38)
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Thus, if r = 3, we can calculate the skewness, γ1. Using our previously derived results and
a binomial expansion of the term in the numerator, we find this as
γ1 =
1
σ3
[E(m3)−3〈m〉E(m2)+2〈m〉3]
=
1
σ3
[E0(m3)+E1(m3)−3〈m〉E(m2)+2〈m〉3], (2.39)
which, upon substitution, gives
γ1 =
1
σ3
[
α3
ψ−1
(ε)2
(ψ)2
(
ε+2
ψ+2
(3+ψ− ε)−3
)
+
(
1+
3αε
ψ+1
(1−〈m〉)−3〈m〉
)
E0(m)
+
(
1+(3+α
ε+2
ψ+2
−3〈m〉)α ε+1
ψ+1
−3〈m〉
)
E1(m)+2〈m〉3
]
. (2.40)
Similarly, taking r = 4, we get the fourth central moment, or the kurtosis (β2). However,
the excess kurtosis γ2 = β2−3 is more convenient since γ2 = 0 for a Gaussian distribution.
γ2 =
1
σ4
[E0(m4)+E1(m4)−4〈m〉(E0(m3)+E1(m3))
+6〈m〉2(E0(m2)+E1(m2))−3〈m〉4]−3. (2.41)
The partial expectation values required are
E1(m3) =
[
1+
α(ε+1)
ψ+1
(
3+
α(ε+2)
ψ+2
)]
E1(m),
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E0(m3) =
α3
ψ−1
(ε)2
(ψ)2
[
ε+2
ψ+2
(3+ψ− ε)−3
]
+
(
1+
3αε
ψ+1
)
E0(m),
E1(m4) = α4
ε−1
ψ−1
(ε)4
(ψ)4
+
[
6
(
1+
α(ε+1)
ψ+1
(3+
α(ε+2)
ψ+2
)
)
−11α(ε+1)
ψ+1
−5
]
E1(m),
and
E0(m4) =
α4
ψ−1
(ε)3
(ψ)3
[
ε+3
ψ+3
(4+ψ− ε)−4
]
+
6α3
ψ−1
(ε)2
(ψ)2
[
ε+2
ψ+2
(3+ψ− ε)−3
]
+
[
1+
7αε
ψ+1
]
E0(m).
Similarly, one can obtain expressions for the skewness and the kurtosis corresponding to
the conditional probability distribution functions derived above, i.e. P(m|0) and P(m|1).
This can be done by computing the “conditional” expectations,
〈 f (m)〉s =
∞
∑
m=0
f (m)P(m|s),
s = 0,1, of the bracketed term in Eq. (2.37). This leads to a general expression for the
skewness (catering for the two states of the promoter), denoted as
γs1 =
〈(
m−〈m1〉s
σs
)3〉
s
=
1
σ3s
[
〈m3〉s−3〈m1〉s〈m2〉s+2(〈m1〉s)3
]
.
Hence, when s = 0 and 1, respectively for the “off” and “on” states, we get
γ01 =
ψ−1
σ30(ψ− ε)
[
E0(m3)−3〈m1〉0 E0(m2)+2(〈m1〉0)3 ψ− εψ−1
]
, (2.42)
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γ11 =
ψ−1
σ31(ε−1)
[
E1(m3)−3〈m1〉1 E1(m2)+2(〈m1〉1)3 ε−1ψ−1
]
. (2.43)
The corresponding expressions for the excess kurtosis can be obtained from,
γs2 =
〈(
m−〈m1〉s
σs
)4〉
s
=
1
σ4s
[
〈m4〉s−4〈m1〉s〈m3〉s+6(〈m1〉s)2〈m2〉s−3(〈m1〉s)4
]
−3,
implying that,
γ02 =
ψ−1
σ40(ψ− ε)
[
E0(m4)−4〈m1〉0 E0(m3)
+6(〈m1〉0)2 E0(m2)−3(〈m1〉0)4 ψ− εψ−1
]
−3, (2.44)
γ12 =
ψ−1
σ41(ε−1)
[
E1(m4)−4〈m1〉1 E1(m3)
+6(〈m1〉1)2 E1(m2)−3(〈m1〉1)4 ε−1ψ−1
]
−3, (2.45)
where, in each case above,
σ2s = 〈m2〉s− (〈m1〉s)2
and Es(·) denotes the partial expectation. In the next Chapter, we will use these analysis
results to obtain the control coefficients. We end this chapter by investigating the behavior
of the skewness and the kurtosis for both the conditional and the marginal distributions, as
one of the parameters, Keq, varies. Our results are summarized in Fig. 2.4 below.
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Figure 2.4: The relationship between the excess kurtosis for the marginal distribution, γ2
and the parameter Keq, while α = 6.7 and ε = 3 (as in [40]).
Fig. 2.4 illustrates that the observable, γ2 in this case, decreases as Keq increases. This curve
is asymptotic to the line Keq = 0, but γ2 → 0.150 as Keq → ∞. The relationship between
the observables γ1,γ11,γ
0
1, γ
1
2, γ
0
2 and the parameter Keq is similar to the one depicted in this
figure. Increasing the parameter Keq forces the distributions to become less leptokurtic, i.e.
less frequencies remain trapped in small ranges of the distribution.
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2.14 Transcriptional factor–operator binding and unbind-
ing equilibrium
In this section, we look at how changes in Keq affect the shapes of the distributions. Tran-
scriptional factors bind to the operator sites of the promoter thereby enabling transcrip-
tion. This binding process is reversible, and so at any given time, an equilibrium can
be attained between the binding and unbinding processes. As mentioned before, we can
define an effective equilibrium constant Keq = konkoff , for the reversible processes of activa-
tion/deactivation of the gene.
Results displayed in Figs. 2.5 and 2.6 below show that increasing Keq results in a shift of
the non-zero probability ranges towards higher values of m, stretching the curves along the
m-axis and reducing their peaks. A decrease in Keq generates the reverse transformations.
Therefore, increasing Keq reduces the excess kurtosis but increases the standard deviations,
yet decreasing Keq increases the excess kurtosis and reduces the standard deviation. Cor-
respondingly, Figs. 2.5 is flatter and wider as compared to Fig. 2.6 which is peaked and
narrow. The same plots or observations could have been obtained had P(m|0) been used
instead.
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Figure 2.5: The conditional probability P(m|1), with parameters Keq = 1.67,α = 150, and
ε = 72000 (as in [30]).
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Figure 2.6: The effect of decreasing Keq on the conditional probability P(m|1), parameters
Keq = 0.42,α = 150, and ε = 72000 (as in [30]).
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Chapter 3
Extension of Metabolic Control Analysis to genetic systems
3.1 The stochastic control coefficients
Explanations on how cells operate within strict and safe parameters in the presence of
noise and how cells can use noise, for instance to amplify certain responses can be forged
once one has established the expressions for the moments of the distributions for the
biomolecules. These issues can be addressed by using sensitivity analysis. Specifically,
Metabolic Control Analysis (MCA), is a form of sensitivity analysis adapted to biochemi-
cal processes [37]. It uses control coefficients to assess relative changes in any observable
when parameters change. These are mathematically defined by
CXρ =
∂ lnX
∂ lnρ
≈ ∆ lnX
∆ lnρ
, (3.1)
where X is an observable and ρ, a parameter. In our model diagram, the observables include
the mean and standard deviation for the marginal and conditional probability distributions
of the mRNA, the skewness and the kurtosis, and the parameters, ρ, could be either of α,ε
or Keq. The analytical expressions for the moments are in terms of these parameters and
the control coefficients are also calculated for these three parameters, α,ε and Keq. Keq
changes when, for instance, the strength of the promoter is changed by manipulating its
DNA sequence, a central technique in genetic engineering. Experimentally, we can mea-
sure the change in X for a given change in ρ, which allows us to relate theory to experiment,
through the approximation of CXρ using finite differences shown above.
Using the moments of the marginal and conditional distributions, we get the expressions
for the control coefficients for the respective averages and standard deviations. Some of
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the expressions for the control coefficients are quite unmanageable and too long to be pre-
sentable. Instead numerical values for all the control coefficients are obtained using Maple,
see Table 3.2, and a few selected expressions are tabulated in Table 3.3. The values of
the parameters were obtained by substituting the values of the rate constants in Table 3.1
below.
Table 3.1: Rate constants in the model and their values
Parameter Value Units Source
kon 0.002 s−1 [40]
koff 0.006 s−1 [40]
km 0.0067 s−1 [40]
k−m 0.001 s−1 [40]
In Table 3.2 below, we see positive and negative control coefficients. A positive control co-
efficient tells us that the observable increases as the parameter increases, while a negative
control coefficient tells us that the observable decreases as the parameter increases. A value
of zero for a control coefficient shows that the observable will not respond in any way to
changes in the corresponding parameter.
The values of the control coefficients in Table 3.2 below give us an idea or help us to ex-
plain how cells maintain behaviour or control stochasticity. The cell can adjust or “tune”
a certain observable without interfering with another observable. As an example, since the
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Table 3.2: The observables and the respective numerical values for the control coefficients,
for α = 150,Keq = 1.2,ε = 72000 (as in [30]).
Observable (X) CXα C
X
ε C
X
Keq
γ1 -0.243 -0.327 -0.337
γ11 -0.288 -0.009 -0.353
γ01 -0.236 -0.410 -0.273
γ2 -0.528 0.579 -0.821
γ12 -0.648 0.139 -0.880
γ02 -0.487 -0.806 -0.641
〈m〉 1 0 0.750
〈m1〉1 1 -0.333 0.667
〈m1〉0 1 0.167 0.667
σ 0.679 -0.239 0.450
σ1 0.654 -0.326 0.375
σ0 0.671 -0.130 0.403
50
value of C〈m〉ε is zero while Cσε = −0.239, the cell can adjust the standard deviation of the
number of mRNA molecules without interfering with the mean by changing ε. In fact, an
increase in the parameter ε is followed by a decrease in the standard deviation, σ. Such a
response has an effect on the CV, which is given by the ratio σ〈m〉 . Keeping 〈m〉 fixed and
decreasing σ means a decrease in the CV or noise. Thus, noise can be regulated in the cell
by concentrating on certain parameters like ε which affect the observables directly linked
to noise.
Results in Table 3.2 also confirm the changes displayed in Figs. 2.5 and 2.6 since C〈m
1〉1
Keq =
0.667, which tells us that the mean number of mRNA increases as Keq increases, hence
the observed shift to the right by the distribution. In contrast, Cγ2Keq = −0.880, implying a
decrease in the corresponding excess kurtosis as the same parameter increases. The dis-
tribution thus becomes flatter and wider at a higher value of Keq. Therefore, increasing
Keq reduces the excess kurtosis but increases the standard deviations, yet decreasing Keq
increases the excess kurtosis and reduces the standard deviation. Correspondingly, Figs 2.5
is flatter and wider as compared to Fig 2.6 which is peaked and narrow.
In Figs 3.1 and 3.2 below, we plot the control coefficients CσKeq and C
γ2
Keq , respectively,
against Keq, to have a general idea of how the response posed by these variables changes as
the parameter Keq changes. These two control coefficients were arbitrarily chosen after ob-
serving that the rest of the control coefficients defining the responses of the other remaining
observables to changes in the parameter Keq were similar to either of these two.
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Table 3.3: Expressions for some of the control coefficients for the average and the standard
deviations of the marginal and conditional probabilities
CXρ Expression
C〈m〉ε 0
C〈m〉α , ∀sC〈m
1〉s
α 1
∀sC〈m1〉sKeq ε−1εKeq+ε−1
C〈m〉Keq
1
1+Keq
C〈m
1〉1
ε
−1
εKeq+ε−1
C〈m
1〉0
ε
εKeq
(ε−1)(εKeq+ε−1)
Cσε
−αεKeq(1+Keq)
2(εKeq+ε−1)(ε(1+Keq)2+Keq(α−1)−1)
Cσα
1
2
[
1+ αKeqε(Keq+1)2−Keq(1−α)−1
]
CσKeq
Keq(3ε2(1+Keq+εK2eq(ε−α)−ε(2−α)(2+Keq)−(2α−1)))+(ε−1)2
2(1+Keq)(ε(1+Keq)2)+Keq(α−1)−1
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Figure 3.1: Behavior of the control coefficient, CσKeq as Keq varies, while α = 6.7 and ε = 3
(as in [40]).
Fig. 3.1 shows that the dependence of the observable σ on the parameter Keq reduces
to negligible values as Keq increases. In fact as Keq → ∞, CσKeq → 0, while as Keq → 0,
CσKeq → 0.710. A similar behavior was observed for the relationship between the control
coefficients Cσ0Keq,C
σ1
Keq ,C
〈m1〉0
Keq , C
〈m1〉1
Keq and the parameter Keq. In relation to Fig. 2.2 (a plot of
σ vs Keq), this graph indicates exactly what one would expect to observe. As σ gets large
enough we will not see a change by making it bigger. As more and more mRNA molecules
are produced, the less responsive the observable(s) become. Fluctuations are minimized
whenever the numbers of molecules are large.
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Figure 3.2: Relationship between Cγ2Keq and Keq, for α = 6.7 and ε = 3 (as in [40]).
The control coefficient Cγ2Keq decreases to a minimum value of −0.885, which occurs when
Keq = 0.539 (Fig. 3.2). At this value of the parameter Keq, while the sensitivity stays
negative, the observable shifts from increasingly sensitive as Keq increases to being less
sensitive. A scrutiny of the end-behaviors of this graph shows that as Keq → ∞, Cγ2Keq → 0,
while Cγ2Keq →−0.434 as Keq→ 0. A similar behavior as depicted on the graph was observed
when the control coefficients Cγ1Keq ,C
γs1
Keq ,C
γs2
Keq (s = 0,1), were plotted against Keq.
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All the observables with positive control coefficients for the parameter Keq increase as Keq
increases. Table 3.2 shows these observables to be the measures of central tendency and
the measures of dispersion for both the marginal and conditional probabilities. The kurtosis
and the skewness have negative control coefficients for the parameter Keq, and, as we would
expect, decrease as the parameter increases (Fig. 3.1). Figs. 3.1 and 3.2 above help us par-
tition the set of all the control coefficients seen in Table 3.2 into two sets, in accordance
with whether they increase or decrease as Keq changes. The set comprising the measures
of central tendency and the measures of dispersion of the marginal and conditional distri-
butions obeys the behavior depicted in Fig. 3.1. The second set, consisting of the skewness
and the kurtosis of the marginal and conditional distributions behaves as shown in Fig. 3.2.
Perhaps, henceforth, the reader has to be made aware of one of the reasons for doing such
a project. This work aims at developing tools that can be used by other researchers, mostly
biologists. Synthetic biologists, for example, produce various copies of genes for various
purposes or targets. Some of these targets include different performance levels measured
by the amount of output (gene products). The ultimate aspiration of all such scientists is
to be able to inflict changes to the natural phenomenon exhibited by systems, i.e. con-
trolling the system. This work therefore serves the purpose of highlighting the key points
leading to a special type of behavior and how it may be achieved. The partitioning of the
responses according to Figs. 3.1 and 3.2 is one form of help one gets from this study. We
have partitioned a set of twelve observables into two sets depending on how they respond
to a particular parameter, Keq in this case. This makes it easy to foretell certain kinds of
behavior before experiments are carried out, thereby saving time and resources.
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3.2 Summation theorems
In my brief discussion of the Theory of Metabolic Control Analysis (MCA), last section
of Chapter 1, I mentioned that this theory is based on control coefficients. A particular
metabolism can be influenced by a number of enzymes meaning that the overall output, i.e.
the distribution of an observable, in a metabolic pathway is affected by activities of at least
one enzyme. In simple words, we say that control over the distribution of the metabolite is
shared. One of the summation theorems says that the sum of all the concentration control
coefficients for the enzymes affecting a particular metabolism should add up, and the sum
is 0 [44]. Thus, there exists a negative response of equal magnitude somewhere along the
pathway by a certain enzyme meant to cancel or negate a positive effect on the metabolite
distribution by another enzyme, so that the sum of zero is maintained.
Let CXω be the control coefficient measuring the response of the observable X to a change
in a rate constant ω = {km,k−m ,kon,koff}. Using the chain rule one can easily establish that
CXω =
ω
X ∑ρ
∂X
∂ρ
∂ρ
∂ω
=∑
ρ
CXρ
ω
ρ
∂ρ
∂ω
where, as before, ρ = {α = km
k−m
,ε = 1+ kon
k−m
,Keq = konkoff}. Hence,
∑
ω
CXω =∑
ω
[
∑
ρ
CXρ
ω
ρ
∂ρ
∂ω
]
=∑
ω
[
CXα
ω
α
∂α
∂ω
+CXε
ω
ε
∂ε
∂ω
+CXKeq
ω
Keq
∂Keq
∂ω
]
56
= CXα
[
km
α
∂α
∂km
+
k−m
α
∂α
∂k−m
+
kon
α
∂α
∂kon
+
koff
α
∂α
∂koff
]
+ CXε
[
km
ε
∂ε
∂km
+
k−m
ε
∂ε
∂k−m
+
kon
ε
∂ε
∂kon
+
koff
ε
∂ε
∂koff
]
+ CXKeq
[
km
Keq
∂Keq
∂km
+
k−m
Keq
∂Keq
∂k−m
+
kon
Keq
∂Keq
∂kon
+
koff
Keq
∂Keq
∂koff
]
= CXα
[
1−1+0+0
]
+CXε
[
0+
1
ε
−1+1− 1
ε
+0
]
+ CXKeq
[
0+0+1−1
]
⇒ ∑
ω
CXω = 0.
Hence, regardless of the observable, X , chosen, the sum (inside the square brackets) re-
mains zero since the parametric sensitivities, ωρ
∂ρ
∂ω , will sum to zero, therefore a summation
theorem holds for any observable one may choose. This means that the Metabolic Con-
trol Analysis theory can be extended to genetic control mechanisms. Gene expression is
stochastic, owing to the number of genes themselves, as well as some other factors involved
in the expression process, for example the transcription factors, but still there is control over
the process. As an example, an increase in the rate of one reaction, be it transcription or
mRNA degradation, is matched by an increase or decrease of another reaction meant to
negate the effect so that the cell continues to function normally without having an excess
of a certain type of molecule relative to the others.
As illustrated before when we discussed the control coefficients, C〈m〉ε = 0 and Cσε =−0.239,
gene activation and mRNA dynamics can be utilized antagonistically in the control of noise.
The parameter ε= 1+ kon
k−m
links mRNA dynamics to the activities on the promoter. Thus, for
instance, by increasing the promoter activity, which increases this parameter, the gene has
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to keep the rate at which mRNA degrades constant so that noise is decreased. Conversely,
if mRNA degradation is high, then noise is high since the parameter ε becomes small. To
lessen the noise, the gene has to increase the activity of the promoter, which increases the
number of mRNA molecules.
This chapter concentrated on the response by the key qualities (moments), that describe the
distributions, to changes in parameters. The results, mainly the control coefficients, have
been given both in numerical form, and, for some, in terms of expressions. We can also
explore the dependence of the distributions on the parameters. This is done in the following
chapter.
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Chapter 4
The Stochastic Bifurcations
4.1 Dependence of the conditional probabilities on the pa-
rameter ε
In this chapter, we look at how the distributions themselves, not particular aspects or quali-
ties in them, would respond to changes in parameters. In particular, and for interest’s sake,
we will study how the distributions behave when ε, which links the dynamics of the mRNA
to the dynamics of the promoter, changes.
We begin by seeing what the conditional probability distributions, as well as the marginal
distributions, look like when plotted using selected values of the parameters, and then how
they look like as we change one of the parameters. The results are presented in graphical
form. The last section of this chapter contains results of a numerical simulation of the same
model, which are also presented in graphical form. This does not only enable a comparison
of the results obtained from the model using the two different approaches, but also presents
us with the opportunity to compare our results with simulation results obtained from a sim-
ilar model studied by other researchers [68].
Using the parameters from [30], we first plot the conditional probability distribution func-
tion, P(m|1), which we derived in Chapter 2 Fig. 4.1. We arbitrarily chose to display
P(m|1); P(m|0) is identical and symmetrical for these parameters. Our aim here is to spot
the effects of altering the values of the parameters, e.g. ε, on these distributions. Given
the three parameters ε,α and Keq, one may be interested in the selection of particular pa-
rameters that influence a particular observable most. Qualitative changes in probability
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distributions as parameters change, called stochastic bifurcations, can be investigated by
examining the changes in the probability distributions as parameters change.
To get a rough idea about how (or even whether) the distributions respond to changes in
parameters, we fix values of two of the parameters, namely α and Keq, and then vary ε. As
discussed in Chapter 2, the parameter ε links the time scales of the two subsystems, one
regarding mRNA dynamics and represented by α, and the other, standing for the dynamics
on the promoter and represented by Keq. Results from the preceding chapter show the effect
that an increase in the parameter ε had on the standard deviation, i.e., an increase in this
parameter results in a decrease in the standard deviation. As can be observed upon reducing
ε (from Fig. 4.1 through Fig. 4.3 below), the distributions shift from being symmetrical to
being non-symmetrical. P(m|0) eventually ceases having a maximum and becomes mono-
tonic while P(m|1) still has a maximum but is more flattened and negatively skewed. This
indicates a qualitative behavioral change by the system.
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Figure 4.1: The conditional probability, P(m|1), of having m mRNA molecules given that
the gene is in an active state, for α = 150,ε = 72000,Keq = 1.2 (as given in [30]).
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Figure 4.2: A change in the shape of P(m|s) [P(m|0) continuous and P(m|1) dashed] rel-
ative to Fig. 4.1 when the value of ε is reduced from 72000 to 2.44, with α = 150 and
Keq = 1.2 (values of α and Keq are as given in [30]).
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Figure 4.3: An illustration of the changes in behavior relative to Figs. 4.1 and of the con-
ditional probability distributions, P(m|s) [P(m|0) continuous and P(m|1) dashed] when
ε = 1.36, α = 150, Keq = 1.2 (values of α and Keq are as given in [30]).
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Figure 4.4: Logarithmic plot of the skewness, for the active distribution, γ11, against ε, with
α = 150 and Keq = 1.2 (as given in [30]).
Fig. 4.4 shows that as the parameter ε increases, the skewness of P(m|1) decreases. This
can also be predicted from Table 3.2, where we have Cγ
1
1
ε = −0.009, implying that the
distribution P(m|1) becomes less skewed (more symmetrical) as ε increases, as seen in
Fig. 4.1.
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4.2 The marginal distribution and its response to changes
in the parameter ε
In Figs. 4.1 through Fig. 4.3 above, we have seen the graphical representations of the con-
ditional probabilities plotted using different values for the parameter ε, while the other two
parameters, α and Keq remain fixed. In this section we explore, in a similar manner, the
changes that the marginal distribution undergoes. This should help us reveal the overall
effect on the distribution of the state-to-state transitions by the promoter. The marginal
distribution can be easily obtained experimentally by sampling from a population of non-
synchronized cells.
The marginal probability is a sum of the two joint probabilities, P(0,m) and P(1,m),
m ∈ [0,∞), and hence as one would anticipate, should respond to changes in parameters.
Fig. 4.5 below shows, for some selected values of the parameters α, ε and Keq, what P(m)
looks like, whereas the subsequent figures, Fig. 4.6 through Fig. 4.8, illustrate the changes
that this same distribution undergoes when ε is changed (reduced). As was the case with
the conditional distribution P(m|0), the marginal distribution is observed to shift from be-
ing symmetrical to non-symmetrical. As we noted in Chapter 3, decreasing ε leads to an
increase in the standard deviation, meaning that the distributions become broader: variabil-
ity increases. In Fig. 4.8 we observe the marginal probability distribution also changing
from having a global maximum at some value of m > 0, as observed in Fig. 4.1 through
Fig. 4.3, to having a local maximum at some m> 0, and the global maximum at m= 0. This
is a clear indication of the fact that a change in parameters causes the system to undergo
stochastic bifurcations. Unlike in the deterministic case where bifurcations are recognized
through the degeneration of stable fixed points to either unstable or double stable points,
bifurcations in stochastic systems are noted differently. The notion of a stable fixed point
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is not well-defined in stochastic systems, instead a bifurcation occurs in stochastic systems
whenever a qualitative change occurs in the shape of the distribution. For instance, the
appearance of additional peaks or a change in the sign of the skewness both indicate a
bifurcation.
Figure 4.5: A plot of the marginal probability distribution for the values of the parameters
α = 150, ε = 72000 and Keq = 1.2 (as in [30]).
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Figure 4.6: A plot of the marginal probability distribution for the values of the parameters
ε = 2.44, α = 150 and Keq = 1.2 (values of α and Keq are as given in [30]).
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Figure 4.7: A plot of the marginal probability distribution for the values of the parameters
ε = 1.96, α = 150 and Keq = 1.2 (values of α and Keq are as given in [30]).
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Figure 4.8: A plot of the marginal probability distribution for the values of the parameters
ε = 1.36, α = 150 and Keq = 1.2 (values of α and Keq are as given in [30]).
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4.3 Derivation of the bifurcation analysis equation for the
conditional probability P(m|0)
The bifurcation we observed above is mainly due to a change of the probability distribution
of P(m|0) from having a maximum at some value of m > 0, to having a maximum at the
point m = 0. This stochastic bifurcation occurs when the rate of change of P(m|0) with
respect to m, evaluated at m = 0, equals zero. Expressed, mathematically, this is
dP(m|0)
dm
∣∣∣∣
m=0
= 0.
This equation defines a surface, in parameter space, on one side of which the distribution
has a maximum, while on the other side, it is monotonic. After differentiation of P(m|0),
we find that
dP(m|0)
dm
= β
[(
lnα−Ψ(m+1)+Ψ(ε+m)−Ψ(ψ+m)
)
Ω+
dΩ
dm
]
,
where,
β =
1
ψ− ε
αm
m!
(ε)m
(ψ)m
,
Ω = (α+ψ+m− ε) 1F1(ε+m;ψ+m;u0)−α ε+mψ+m 1F1(ε+m+1;ψ+m+1;u0)
−mψ+m−1
ε+m−1 1F1(ε+m−1;ψ+m−1;u0),
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⇒ dΩ
dm
= 1F1(ε+m;ψ+m;u0)
+(α+ψ+m− ε)
∞
∑
n=0
(ε+m)n
(ψ+m)n
un0
n!
n−1
∑
p=0
(
1
p+ ε+m
− 1
p+ψ+m
)
+α
ε+m
ψ+m
∞
∑
n=0
(ε+m+1)n
(ψ+m+1)n
un0
n!
n−1
∑
p=0
(
1
p+ψ+m+1
− 1
p+ ε+m+1
)
+m
ψ+m−1
ε+m−1
∞
∑
n=0
(ε+m−1)n
(ψ+m−1)n
un0
n!
n−1
∑
p=0
(
1
p+ψ+m−1 −
1
p+ ε+m−1
)
−α ψ− ε
(ψ+m)2 1
F1(ε+m+1;ψ+m+1;u0)
−
[
ψ+m−1
ε+m−1 −m
ε−ψ
(ε+m−1)2
]
1F1(ε+m−1;ψ+m−1;u0).
Γ(m) =
R ∞
0 t
m−1e−tdt = (m−1)! defines the Gamma function, Ψ(·) is the digamma func-
tion, and the derivative of the confluent hypergeometric function with respect to any of its
parameters is as defined in [41]. Inserting m = 0 and equating the result to zero, we get
dP(m|0)
dm
∣∣∣∣
m=0
=
Ω
ψ− ε(lnα−Ψ(1)+Ψ(ε)−Ψ(ψ))+
1
ψ− ε
dΩ
dm
∣∣∣∣
m=0
= 0 (4.1)
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where,
1
ψ− ε
dΩ
dm
∣∣∣∣
m=0
=
1
ψ− ε 1F1(ε;ψ;u0)−
α
ψ2 1
F1(ε+1;ψ+1;u0)
− ψ−1
(ψ− ε)(ε−1) 1F1(ε−1;ψ−1;u0)
+
∞
∑
n=0
[
(ε)n
(ψ)n
un0
n!
n−1
∑
p=0
(
α+ψ− ε
(p+ ε)(p+ψ)
− ε+n
ψ+n
α
(p+ ε+1)(p+ψ+1)
)]
.
We will carry on with the investigation of this bifurcations condition at a later time. This
involves obtaining, using the equation derived above, values of ε at which Eq. 4.1 is satis-
fied given values of the other parameters, α and Keq. It is unfortunate that at this moment,
the numerics are proving to be difficult.
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4.4 A simulation of the simple gene expression model
In this section, we explore the same model using a different approach, simulation. The rea-
son for doing this is to see if we can get the same graphical representation of the marginal
distribution as that obtained from the analytical approach. This comparison is necessary
because there is a difference in our theoretical results and the results presented in [68].
We substitute the values of the parameters given in [68] in our analytical expression for
the marginal distribution as well as in a simulation to produce two graphs, Fig. 4.9 and
Fig. 4.10, which we compare. We also compare the results displayed on these two graphs
to those obtained through simulation in [68].
Simulations help us get the overall picture of the outcome from a model, or simply what
to expect. A simple model like ours can be easily coded, for instance using Matlab, and
simulated. Hence, a simulation would be faster if one is only concerned with simply getting
an idea about how a model performs. It is, however, difficult to explore the performance
of the model, for example it would be hard and time consuming to carry out sensitivity or
bifurcation analysis through a simulation. The difficulty is normally two-fold, since the
values of the parameters are often not precisely known, yet even if they are known, one has
to do a lot of sampling.
Using the Gillespie stochastic simulation algorithm [35, 43], we obtain the simulation re-
sults, displayed in Fig. 4.10, for our model. Compared to the result for the marginal distri-
bution from the analytical approach, Fig. 4.9, the results are similar—an asymmetrical and
uni-modal curve. The parameters used to produce these curves were obtained from [68],
who reported different simulation results—an asymmetrical bimodal mRNA distribution
with peaks near m = 0 and m = 5. There are no analytic expressions for the distributions
given in [68] and there is no explanation as to whether a single simulation or multiple in-
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dependent simulations were performed to come up with the result. We go along with the
observation that the mRNA distribution is asymmetrical but disagree on it being bimodal.
The results in Figs. 4.10 were produced from a long simulation performed over a period
of two days. This result closely resembles the analytical distribution displayed in Fig. 4.9,
i.e. the analytical and numerical results should eventually converge although it takes a lot
of data for this to happen. A lot of sampling has to be done or, alternatively, the program
has to be run for a long time to get reasonable simulation results. Without analytical ex-
pressions to compare with, it is therefore easy for one to get a wrong conclusion from the
simulation result only.
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Figure 4.9: Analytical result showing the marginal probability distribution, P(m), for α =
6.7, ε = 1.2 and Keq = 0.33 (as given in [68]).
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Figure 4.10: Simulation result showing the marginal probability distribution, P(m), for
α= 6.7, ε= 1.2 and Keq = 0.33 (as given in [68]). Two samples were collected from a sim-
ulation performed in two 24–hour intervals, each interval with 100000 mRNA molecules,
i.e. a total of 200000 mRNA molecules.
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Chapter 5
Discussions and Conclusions
Biological systems depend on the ability of the cells in them to function normally and to
maintain behavior. Most of the important cellular processes, for example gene expression,
operate with very low copy numbers. Chemical reactions which result in changes in num-
bers of molecules occur randomly, and the molecule numbers change by very small integer
values. Involvement of each molecule is indispensable, a small change in the number of
molecules of a particular species occasions pronounced relative changes in the reaction
probabilities. The result is a stochastic environment where all events occur probabilisti-
cally.
The stochasticity complicates the mathematical modelling of biochemical systems which
has to take into account the randomness of events, if the true nature of the system is to be
revealed. Stochastic methods, such as the Chemical Master Equation (CME) [35], can be
used to obtain the probability distributions describing the probabilities of the system being
in any given state. Unless a model is simplified, the resultant CME is a huge set of differ-
ential equations and is difficult to solve due to huge dimensionality. Simple and solvable
CMEs can be derived analytically for correspondingly simple models to obtain expressions
for the probability distributions. However, such models do not represent real biological
systems which are large and complicated, even though invaluable insight can be gained
from them. Large and complicated models can be studied using simulations [8, 67]. One
of the problems associated with simulations is that it is hard to obtain expressions for the
probabilities and hence for other quantities, for example the moments. Expressions derived
in terms of the model parameters can be easily used by other researchers. They also enable
investigation of the properties of a system.
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There are two common ways to study a stochastic biochemical system. One may decide to
do a bifurcation analysis, which reveals qualitative changes in the behavior of the system
as parameters change, or one can apply the theory of Metabolic Control Analysis. This
latter theory uses control coefficients to measure responses of observables when parame-
ters change. If one has the expressions for the probabilities, then one can assess the way
each observable responds to a particular parameter change by calculating a control coeffi-
cient for it. The numerical value of a control coefficient tells one whether the observable
increases or decreases when the parameter of concern changes, and also gives the magni-
tude of the response. A greater value for a control coefficient tells us that the parameter, or
the step that it represents in a pathway, has greater control over the particular observable
compared to others. On the other hand, by plotting graphs that represent the distribution
functions and observing the way they change when values of parameters are changed, one
can also tell if the system described undergoes stochastic bifurcations.
This study focussed on a simple solvable stochastic gene expression model without feed-
back. Genes typically appear in not more than two copies in a cell, and hence genetic
systems are subject to stochasticity. In this model, the gene is considered to transition
between two states, “on” and “off”, and this occurs randomly due to stochasticity. This
randomness also carries over to the production of the gene products, which are then pro-
duced in bursts [68]. The two-state scenario on the gene itself results in an infinite set of
ordinary differential equations describing the probability rates of obtaining a certain num-
ber of mRNA molecules when the gene is in either state. I solved these equations to obtain
the stationary joint probability distributions. Taking into account the fact that we may need
to count the number of molecules regardless of the state of the gene, I derived the marginal
probability distribution, as a sum of the two joint probability distributions. I also derived the
conditional probability distribution functions from the two joint probability distributions,
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which give the probability of obtaining a certain number of molecules given the gene is in
a particular state. For each of these conditional distributions, as well as for the marginal
probability distribution, expressions were obtained for the related moments, namely the
mean, the variance, the skewness and the kurtosis. These four were basically used as the
observables in this work and help to capture the numerical values of the important features
of the distributions. I carried out sensitivity analysis using MCA and developed expressions
for the control coefficients of the moments, which I evaluated using values of the parame-
ters from the literature. The expressions for the probability distributions were also used to
obtain graphical representations of the probabilities and bifurcation analysis was done.
The results show a successful extension of MCA to genetic systems. In fact, if one suc-
cessfully derives expressions for the probability distributions, and hence the moments, one
should be able to obtain expressions for the control coefficients. Moreover, the stochastic
control coefficients obtained do satisfy one of the summation theorems governing classi-
cal MCA. The results also corroborate the general observation that noise decreases as the
number of molecules increase and that the genetic system undergoes a qualitative behav-
ioral change, stochastic bifurcation, as the parameters change. There are parameter regimes
in which the bifurcation occurs and in these regimes, the parameter space is split into two
regions where the system displays different types of behavior, basically shifting from hav-
ing a maximum to being monotonic. The summation theorem enables us to link the system
variables with the kinetics of the separate enzyme catalysed reactions in the system and its
fulfilment helps us get the insight that reactions in the system occur antagonistically. While
one reaction boosts the level of a certain metabolite, we expect another reaction to be uti-
lizing the same metabolte and bringing down the level of this metabolite. This enables the
cell to work normally and maintain behavior.
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5.1 And where do we go from here?
I mentioned in section 1.3, Chapter 1, that my work was not covering translation. The
next step in this work is to include this process. A three–stage model, involving gene
activation/deactivation, mRNA and protein dynamics will be considered next, with the ob-
jective of obtaining the moments for the protein probability distributions and developing
the control coefficients for them. This work has already begun. In section 4.3, Chapter 4, I
indicated that the analysis of the equation
dP(m|0)
dm
∣∣∣∣
m=0
= 0
would be suspended for now. This was mainly due to time constraints in my program. This
equation will be revisited with the aim to obtain the phase diagram, which, in parameter
space, will show regions where bifurcations take place.
The model analysed here excluded feedback, as stated in the assumptions, section 2.2. The
feedback refers to interference with the promoter activity by the proteins produced by the
gene itself or other genes (for example see [28]). This should allow the model to reflect
a real genetic system, characterized by a complex model and in which a gene does not
operate in isolation.
An example of a more complex model that I intend to study is the lactose (lac) operon [1].
The operon encodes genes for lactose permease and for β-galactosidase. The former is
required to allow lactose into the cell, while the latter catalyzes hydrolysis of lactose. In
the absence of lactose, a repressor binds to the operator region of the DNA and inhibits
transcription. The β-galactosidase reaction occasionally isomerizes lactose to allolactose
instead of hydrolyzing the disaccharide. Allolactose in turn can bind to the lac repressor,
inactivating it and allowing transcription of the genes in the operon to proceed. Since we
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need the permease and hydrolytic enzyme to get lactose into the cell and to convert it into
allolactose, how is the operon induced in the first place? Binding of the repressor to the
operator is an equilibrium process. Occasionally, the repressor will dissociate even in the
absence of allolactose and allow transcription to proceed. Induction of the operon is thus a
paradigm for rare but biochemically significant events. Given that this system has been well
studied, for example in [1], all the necessary kinetic parameters are known, which makes
this system ideal for the theoretical study of rare events in molecular biology. My stochastic
MCA theory will allow me to study the sensitivity of the induction process, including the
frequency with which the uninduced operon “leaks” and allows its genes to be transcribed,
to various parameters of the model.
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